# Terex Corp: Form 10-K for the period ended Dec 31, 2025

- Company: [Terex Corp](/companies/tex.md) (CIK 97216)
- Form: 10-K
- Filed: 2026-02-13
- Accepted by EDGAR: Feb 13, 2026, 15:50 ET
- Period: 2025-12-31
- Accession: 0000097216-26-000035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97216/000009721626000035/tex-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97216/000009721626000035/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $5.42bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $4.37bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $1.05bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $39.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2025-01-01 to 2025-12-31 | $576.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | $475.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2025-01-01 to 2025-12-31 | $177.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $71.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | $221.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | $3.33 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | $3.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 66,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $440.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $118.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months, 2025-01-01 to 2025-12-31 | $45.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2025-01-01 to 2025-12-31 | $56.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-12-31 | $772.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $2.73bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $6.14bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $1.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $4.04bn | us-gaap:Liabilities |
| Current portion of debt | at 2025-12-31 | $6.0m | us-gaap:DebtCurrent |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97216/000009721626000035/tex-20251231.htm

Filed Feb 13, 2026.
Source: SEC EDGAR, the filing index for accession 0000097216-26-000035. Last ingested by Listed: Nov 12, 2026, 19:18 ET. No prices; not investment advice.
